Clemastine
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 613 publications
Occupational Anaphylaxis to Piperacillin-Tazobactam in a Nurse: A Case Report.
Journal: Journal of investigative medicine high impact case reports
Published: May 13, 2026
Investigational approaches to multiple sclerosis therapy.
Journal: Current opinion in neurology
Published: April 29, 2026
Neuroinflammation mediated repurposing of clemastine for Alzheimer's disease through network pharmacology, molecular dynamics, and experimental validation studies.
Journal: Inflammopharmacology
Published: April 24, 2026
Green spectrofluorimetric determination of clemastine using nitrogen and phosphorus Co-doped carbon quantum dots with face-centered design optimization and sustainability assessment.
Journal: RSC advances
Published: March 05, 2026
Oligodendrocyte-specific Fus depletion preserves CA1 single-unit fidelity and stabilizes network dynamics during chronic recording.
Journal: Journal of neural engineering
Published: March 04, 2026
Clemastine fumarate promotes myelin repair in a nonhuman primate model of demyelination characterized by absent spontaneous remyelination.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 20, 2026
Evaluation of Clemastine's Effects on Clinical and Electrodiagnostic Parameters in Individuals With CTS: A Preliminary Placebo-Controlled Double-Blind RCT.
Journal: Archives of rehabilitation research and clinical translation
Published: January 01, 2026
Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway.
Journal: Acta pharmacologica Sinica
Published: December 31, 2025
Myelin damage in major depressive disorder: Insights from neuroimaging, molecular mechanisms, and therapeutic perspectives.
Journal: Neuroscience and biobehavioral reviews
Published: December 07, 2025
Targeting enhancing myelin regeneration reverses cognitive deficits in a mouse model of intellectual disability.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: November 11, 2025
Clemastine ameliorates cognitive deficits in an experimental rat model of chronic cerebral hypoperfusion.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: November 04, 2025
Last Updated: 06/30/2026